Buscar resultados de ensayos clínicos
Hyperphosphatemia - 26 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Nicotinic Acid in Hemodialysis Patients With Hyperphosphatemia Condición: Hyperphosphatemia Fecha: 2016-07-14 Intervenciones:
|
Completed |
Nombre del estudio: A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia Condición: Hemodialysis Patients With Hyperphosphatemia Fecha: 2013-04-12 Intervenciones: Drug: PA21 |
Recruiting |
Nombre del estudio: Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD) Condición: Hyperphosphatemia Fecha: 2016-02-09 Intervenciones: Drug: sucroferric oxyhydroxide The non-interventional design allows the observation of patients in a bro |
Recruiting |
Nombre del estudio: An Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia Condición: Hyperphosphatemia Fecha: 2016-02-17 Intervenciones:
|
Completed |
Nombre del estudio: Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease Condición: Hyperphosphataemia Fecha: 2014-05-28 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China Condición: Hyperphosphatemia Fecha: 2016-12-20 Intervenciones:
|
Recruiting |
Nombre del estudio: A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis Condición: Hyperphosphatemia Fecha: 2016-11-11 Intervenciones:
|
Completed |
Nombre del estudio: An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD) Condición: Hyperphosphatemia Fecha: 2016-02-03 Intervenciones:
|
Completed |
Nombre del estudio: Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis Patients Condición: Hyperphosphatemia Fecha: 2012-01-18 Intervenciones: Drug: Lanthanum Carbonate (BAY77-1931) |
Completed |
Nombre del estudio: Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate Condición: Hyperphosphatemia Fecha: 2012-01-18 Intervenciones:
|